EP12.06: The added value of free‐cell DNA analysis over first trimester ultrasound on screening for fetal aneuploidies

By  

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 48, Iss. S1, 2016-09 ,pp. : 318-318

John Wiley & Sons Inc

Access to resources Recommend Favorite

National decline in invasive prenatal diagnostic procedures in association with uptake of combined first trimester and cell‐free DNA aneuploidy screening

By  

AUSTRALIAN AND NEW ZEALAND JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol. 4-8666, Iss. 5, 2015-10 ,pp. : 507-510

John Wiley & Sons Inc

Access to resources Recommend Favorite

National decline in invasive prenatal diagnostic procedures in association with uptake of combined first trimester and cell‐free DNA aneuploidy screening

By  

AUSTRALIAN AND NEW ZEALAND JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol. 55, Iss. 5, 2015-10 ,pp. : 507-510

John Wiley & Sons Inc

Access to resources Recommend Favorite

P11.01: Nuchal translucency at 16 weeks in fetuses with first trimester nuchal translucency >3,5 mm and normal caryotype: what are the issues?

By  

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 48, Iss. S1, 2016-09 ,pp. : 198-198

John Wiley & Sons Inc

Access to resources Recommend Favorite

First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy‐associated plasma protein A, free‐β human chorionic gonadotrophin, placental growth factor, and α‐fetoprotein

By  

PRENATAL DIAGNOSIS, Vol. 35, Iss. 7, 2015-07 ,pp. : 709-716

John Wiley & Sons Inc

Access to resources Recommend Favorite